Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Harteveld
Phase I and Pharmacological Study of the New Topoisomerase I Inhibitor GI147211, Using a Daily X 5 Intravenous Administration
British Journal of Cancer
Cancer Research
Oncology
Related publications
Bioavailability and Pharmacokinetics of Oral Topotecan: A New Topoisomerase I Inhibitor
British Journal of Cancer
Cancer Research
Oncology
A Systematic Study of Nitrated Indenoisoquinolines Reveals a Potent Topoisomerase I Inhibitor
Topoisomerase I Inhibition and Cytotoxicity of 5-Bromo- And 5-Phenylterbenzimidazoles
Bioorganic and Medicinal Chemistry
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Diospyrin, a Bisnaphthoquinone: A Novel Inhibitor of Type I DNA Topoisomerase ofLeishmania Donovani
Molecular Pharmacology
Molecular Medicine
Pharmacology
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Molecular and Cytotoxic Effects of Camptothecin, a Topoisomerase I Inhibitor, on Trypanosomes and Leishmania.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Intravenous (I. V.) Fluid Administration Systems and Incompatibility of Injection
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients With Refractory Hematologic Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Intrapleural Administration of Interleukin 2 in Pleural Mesothelioma: A Phase I-Ii Study
British Journal of Cancer
Cancer Research
Oncology
